Download Risk Assessment made under the Genetically Modified Organisms

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Genome (book) wikipedia , lookup

Public health genomics wikipedia , lookup

Genetically modified crops wikipedia , lookup

Microevolution wikipedia , lookup

Designer baby wikipedia , lookup

Human–animal hybrid wikipedia , lookup

Genetically modified organism containment and escape wikipedia , lookup

Genetic engineering wikipedia , lookup

Genetically modified food wikipedia , lookup

History of genetic engineering wikipedia , lookup

Transcript
Risk Assessment made under the Genetically Modified Organisms
(Contained Use) Regulations 2014
FOR THE GENERATION, BREEDING OR USE OF GENETICALLY MODIFIED ANIMALS
(Form Ani)
Department:
Ref. No:
Supervisor:
Title and Outline Description of Project:
Type of animals involved:
Describe how the genetically modified animal was/will be produced: (eg micro injection,
transfection of embryonic stem cells, viral vector).
If new genetic material is incorporated into the animals, state source of the genetic material:
Is the genetic material capable of horizontal transmission other than as a chromosomal element?
Summarise the modification? (give details of the inserted/deleted gene, including known or speculative gene
function or effect, how gene is modified and the expression system. For multi-component systems continue on or use
a separate page, if necessary).
1
Modified Apr 07
What effect is the modification likely to have on the transgenic animal? (give full details, where known
state effect of mutation/damage/over-expression etc of the gene in the donor species, for knock-outs give expected
effect of losing the gene, consider also whether any physical or behavioural changes are likely to result).
If the animal were to escape could it
have any selective advantage over the wild type population?
result in problems associated with transmission of manipulated genes to other animals?
cause any particular problems/adverse effects to the environment?
If the transgenic animal were to bite or scratch someone could the modification lead to any
additional risks to humans compared to a bite or scratch from a wild type animal? (if yes, please
describe).
The transgenic animals will be held at:
Animal Containment Level
1
2
3
(please circle)
Is the transgenic animal going to be infected/inoculated with a genetically modified microorganism
(if yes complete also Tables 1a and 1c and provide
YES / NO
reference no. for GM risk assessment)
Give location where animals will be held and procedures will be undertaken:
Does the transgenic animal pose a greater risk of harm to human health and safety than the
non-modified equivalent?
(See accompanying note 1. If “Yes” a notification will
YES / NO
be made to the Health and Safety Executive by the
University Biological Safety Officer)
Assessed By:
Signature:
Date:
2
Modified Apr 07
Risk Assessment approved by Genetic Modification Safety Committee
Signature:
Date:
(Biological Safety Officer)
Permission granted by Head of Department for project to be undertaken
Signature:
Date:
(Head of Department)
3
Modified Apr 07
Notes
1. Mechanisms by which a GMO could show an increased risk to human health:

An animal line expressing a human virus receptor may create a novel human disease
reservoir.

Novel or increased allergenicity, toxicity, or production of biologically active proteins

Altered behaviour such as enhanced aggression

Increased size
2. In order to undertake the work detailed above the requirements of the Animals (Scientific
Procedures) Act 1986 must also be met. A Project Licence and Personal Licence will be
required. If necessary, investigators should contact Veterinary Services for further details.
3. The person responsible for the day to day care of the animals in the holding facility must be
informed that transgenic animals are being used and relevant health and safety information
provided.
4. All carcasses and tissue waste must be disposed of by incineration as clinical waste. The use
of surplus animals for other purposes must be risk assessed. Carcasses, tissues or surplus
animals must not be used as feedstuffs for other animals.
4
Modified Apr 07